EPI-7386 is a novel N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer-MedSci.cn

EPI-7386 is a novel N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer

Le Moigne, R; Banuelos, CA; Mawji, NR; Tam, T; Wang, J; Jian, K; Andersen, RJ; Cesano, A; Sadar, MD; Zhou, HJ; Virsik, P

ANNALS OF ONCOLOGY, 2019; 30 (): 189

科室
- - 订阅+
  - 更多科室
工具
服务